Actieve functies van Brooks Rahmer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
Loopbaan van Brooks Rahmer
Eerdere bekende functies van Brooks Rahmer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MYOKARDIA, INC. | Investor Relations Contact | 01-05-2019 | 01-01-2021 |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Investor Relations Contact | 2 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Brooks Rahmer
- Ervaring
